TIAA CREF Investment Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $2.22M | Buy |
172,687
+4,053
| +2% | +$52.2K | ﹤0.01% | 1949 |
|
|
2018
Q4 | $2.56M | Buy |
168,634
+5,994
| +4% | +$91.1K | ﹤0.01% | 1810 |
|
|
2018
Q3 | $3.25M | Sell |
162,640
-75,959
| -32% | -$1.52M | ﹤0.01% | 1865 |
|
|
2018
Q2 | $4.65M | Buy |
238,599
+12,211
| +5% | +$238K | ﹤0.01% | 1646 |
|
|
2018
Q1 | $4.56M | Buy |
226,388
+81,571
| +56% | +$1.64M | ﹤0.01% | 1607 |
|
|
2017
Q4 | $1.92M | Sell |
144,817
-12,621
| -8% | -$167K | ﹤0.01% | 2161 |
|
|
2017
Q3 | $2.91M | Sell |
157,438
-15,585
| -9% | -$288K | ﹤0.01% | 1943 |
|
|
2017
Q2 | $3.18M | Buy |
173,023
+49,209
| +40% | +$906K | ﹤0.01% | 1882 |
|
|
2017
Q1 | $2.79M | Sell |
123,814
-8,796
| -7% | -$198K | ﹤0.01% | 1937 |
|
|
2016
Q4 | $4.62M | Buy |
132,610
+5,214
| +4% | +$181K | ﹤0.01% | 1656 |
|
|
2016
Q3 | $3.12K | Sell |
127,396
-1,612
| -1% | -$40 | ﹤0.01% | 1906 |
|
|
2016
Q2 | $3.09M | Buy |
129,008
+13,122
| +11% | +$314K | ﹤0.01% | 1855 |
|
|
2016
Q1 | $2.71M | Sell |
115,886
-539
| -0.5% | -$12.6K | ﹤0.01% | 1913 |
|
|
2015
Q4 | $3.52M | Sell |
116,425
-390
| -0.3% | -$11.8K | ﹤0.01% | 1799 |
|
|
2015
Q3 | $4.64M | Buy |
116,815
+9,045
| +8% | +$359K | ﹤0.01% | 1583 |
|
|
2015
Q2 | $7.44M | Buy |
107,770
+17,742
| +20% | +$1.23M | 0.01% | 1370 |
|
|
2015
Q1 | $4.92M | Buy |
90,028
+8,170
| +10% | +$447K | ﹤0.01% | 1641 |
|
|
2014
Q4 | $3.49M | Sell |
81,858
-342
| -0.4% | -$14.6K | ﹤0.01% | 1882 |
|
|
2014
Q3 | $2.62M | Sell |
82,200
-4,900
| -6% | -$156K | ﹤0.01% | 2057 |
|
|
2014
Q2 | $1.81M | Sell |
87,100
-36,857
| -30% | -$764K | ﹤0.01% | 2361 |
|
|
2014
Q1 | $2.4M | Hold |
123,957
| – | – | ﹤0.01% | 2128 |
|
|
2013
Q4 | $3.01M | Sell |
123,957
-6,600
| -5% | -$160K | ﹤0.01% | 1993 |
|
|
2013
Q3 | $2.8M | Sell |
130,557
-8,699
| -6% | -$187K | ﹤0.01% | 1997 |
|
|
2013
Q2 | $3.1M | Buy |
+139,256
| New | +$3.1M | ﹤0.01% | 1880 |
|